NumerixS Investment Technologies’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
BG
NumerixS Investment Technologies's MRNA Position: Q3 2020 in Review
NumerixS Investment Technologies sold out of Moderna (MRNA) in Q3 2020, closing a stake of 20,366 shares — an estimated $1.31M sold.
NumerixS Investment Technologies first reported a position in MRNA in Q2 2019 and held it in 4 quarters. The position peaked at $1.31M in Q2 2020. 547 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.
- NumerixS Investment Technologies reported no remaining Moderna position as of Q3 2020 after selling out during the quarter.
- NumerixS Investment Technologies sold 20,366 Moderna shares in Q3 2020, an estimated $1.31M.
- NumerixS Investment Technologies first reported a position in Moderna in Q2 2019 and held it in 4 quarters.
- NumerixS Investment Technologies's Moderna position peaked at $1.31M in Q2 2020.
- 547 funds tracked by Wall St. Rank held Moderna as of Q3 2020.
Based on NumerixS Investment Technologies's 13F filing for Q3 2020.